President’s Viewpoint

After the stress of the past two years, 2022 felt like we were starting back into the world again. Despite ongoing pandemic pressures at work and home, we came together as a community this year to advance science and make a difference for patients. We have so much to celebrate — our first in-person annual...

November is Diabetes Awareness Month, an important opportunity to raise awareness about the challenges facing over 37 million people who live with diabetes in the U.S. I am proud of the Endocrine Society’s work advocating for improved prevention, more research, greater access, and lower insulin costs, as well as our contributions to sharing the latest...

The Endocrine Society is pleased to welcome its president for 2022 – 2023, Ursula B. Kaiser, MD, who took office during ENDO 2022 in Atlanta, Ga. A physician-scientist, Kaiser is chief of the Division of Endocrinology, Diabetes, and Hypertension; George W. Thorn, MD, Distinguished Chair in Endocrinology; and director of the Brigham Research Institute at...

Although my presidential term has been 15 months, instead of the typical 12 months (due to ENDO moving from March to June this year), I have to say that this year has flown by. And I couldn’t be prouder and more pleased with how we have created opportunities out of challenges and how we have...

After three years, we are finally on the verge of reuniting face-to-face as a community. I cannot wait to see many of you in Atlanta next month for ENDO 2022. While I am excited to catch up in person with those who travel to Atlanta June 11-14, we are committed to learning from and improving...

The publication of peer-reviewed journals is an integral part of the Endocrine Society’s mission to unite, lead, and grow the global community of researchers, educators, and practitioners in endocrinology. This is an endeavor that can only be accomplished when that same community — our community — vigorously participates in the Society’s journals as authors, editors,...

A longstanding priority of the Endocrine Society is to advance science-based regulatory policies that minimize harms from endocrine-disrupting chemicals (EDCs), and I have been so proud seeing how our members’ work in the European Union (EU) has enabled policy makers to make better decisions using scientific information. For several years now, our EU EDC Task...